Section 3: The actors involved in the development of your country's national SARS-CoV-2 testing policy
|
|
In this section you will be presented matrices within which you will be asked to fill in the actors involved in the development of your country's national SARS-CoV-2 testing strategy, while focusing on different aspects of the strategy. You will be asked to fill this in for 3 different time periods during the pandemic, as well as for the ideal situation.
Please read the instructions carefully, as it will help you fill in the matrices efficiently. |
TABLE 1
Who was involved in the development of the testing strategy for the different target groups in the period between the 1st of January 2020 and the 31st of May 2020 (the first 6 months of the pandemic)?
- The rows show the target groups and the columns show the actors. Please tick the appropriate boxes.
- Select 'not applicable' if there was no strategy for a specific target group.
- You may indicate multiple actors in the 'Other" option. |
|
Laboratory in clinical institution |
Private laboratory |
Animal health laboratory |
Commercial manufacturers of testing kits and materials |
Ministry of Health |
Ministry other than the Ministry of Health |
National public health institute
|
Regional health governance structure |
Public health officials |
National expert and/or advisory groups |
Healthcare professionals and/or management in hospitals |
Healthcare professionals and/or management in long term care |
Not applicable |
Other, namely |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE 2
You have stated that the same actors plus additional actors were involved in the period between the 1st of June 2020 and the 31st of December 2020 as during the first 6 months of the pandemic (Table 1).
Please select which actors were added in the period between the 1st of June 2020 and the 31st of December 2020 (the second 6 months of the pandemic).
Please only select the additional actors. |
|
Laboratory in clinical institution |
Private laboratory |
Animal health laboratory |
Commercial manufacturers of testing kits and materials |
Ministry of Health |
Ministry other than the Ministry of Health |
National public health institute
|
Regional health governance structure |
Public health officials |
National expert and/or advisory groups |
Healthcare professionals and/or management in hospitals |
Healthcare professionals and/or management in long term care |
Not applicable |
Other, namely |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE 2
You have stated that less and/or other actors were involved in the period between the 1st of June 2020 and the 31st of December 2020 as during the first 6 months of the pandemic (Table 1).
Please fill in the matrix and select which actors were involved in the development of the testing strategy for the different target groups in the period between the 1st of June 2020 and the 31st of December 2020 (the second 6 months of the pandemic).
Please select the appropriate options for each row. |
|
Laboratory in clinical institution |
Private laboratory |
Animal health laboratory |
Commercial manufacturers of testing kits and materials |
Ministry of Health |
Ministry other than the Ministry of Health |
National public health institute
|
Regional health governance structure |
Public health officials |
National expert and/or advisory groups |
Healthcare professionals and/or management in hospitals |
Healthcare professionals and/or management in long term care |
Not applicable |
Other, namely |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE 3
You have stated that the same actors plus additional actors were involved in the period from the 1st of January 2021 onwards as during the first 6 months of the pandemic (Table 1).
Please select which actors were added in the period from the 1st of January 2021 onwards (1 year after the start of the pandemic).
Please only select the additional actors. |
|
Laboratory in clinical institution |
Private laboratory |
Animal health laboratory |
Commercial manufacturers of testing kits and materials |
Ministry of Health |
Ministry other than the Ministry of Health |
National public health institute
|
Regional health governance structure |
Public health officials |
National expert and/or advisory groups |
Healthcare professionals and/or management in hospitals |
Healthcare professionals and/or management in long term care |
Not applicable |
Other, namely |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE 3
You have stated that the same actors plus additional actors were involved in the period from the 1st of January 2021 onwards as during the second 6 months of the pandemic (Table 2).
Please select which actors were added in the period from the 1st of January 2021 onwards (1 year after the start of the pandemic).
Please only select the additional actors. |
|
Laboratory in clinical institution |
Private laboratory |
Animal health laboratory |
Commercial manufacturers of testing kits and materials |
Ministry of Health |
Ministry other than the Ministry of Health |
National public health institute
|
Regional health governance structure |
Public health officials |
National expert and/or advisory groups |
Healthcare professionals and/or management in hospitals |
Healthcare professionals and/or management in long term care |
Not applicable |
Other, namely |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE 3
You have stated that the same actors plus additional actors were involved in the period from the 1st of January 2021 onwards as during the first 6 months (Table 1) and second 6 months of the pandemic.
Please select which actors were added in the period from the 1st of January 2021 onwards (1 year after the start of the pandemic).
Please only select the additional actors. |
|
Laboratory in clinical institution |
Private laboratory |
Animal health laboratory |
Commercial manufacturers of testing kits and materials |
Ministry of Health |
Ministry other than the Ministry of Health |
National public health institute
|
Regional health governance structure |
Public health officials |
National expert and/or advisory groups |
Healthcare professionals and/or management in hospitals |
Healthcare professionals and/or management in long term care |
Not applicable |
Other, namely |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE 3
You have stated that less and/or other actors were involved in the period from the 1st of January 2021 onwards as during the first 6 months (Table 1) and second 6 months of the pandemic (If applicable, table 2).
Please fill in the matrix and select which actors were involved in the development of the testing strategy for the different target groups in the period from the 1st of January 2021 onwards (1 year after the start of the pandemic).
Please select the appropriate options for each row. |
|
Laboratory in clinical institution |
Private laboratory |
Animal health laboratory |
Commercial manufacturers of testing kits and materials |
Ministry of Health |
Ministry other than the Ministry of Health |
National public health institute
|
Regional health governance structure |
Public health officials |
National expert and/or advisory groups |
Healthcare professionals and/or management in hospitals |
Healthcare professionals and/or management in long term care |
Not applicable |
Other, namely |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE 4
You have stated that you believe more, less and/or other actors should have been involved in the development of the testing strategy at the very beginning of the COVID-19 pandemic.
Please fill in the matrix and select which actors you believe should have been involved in the development of the testing strategy for the different target groups at the very beginning of the COVID-19 pandemic.
Please select the appropriate options for each row. |
|
Laboratory in clinical institution |
Private laboratory |
Animal health laboratory |
Commercial manufacturers of testing kits and materials |
Ministry of Health |
Ministry other than the Ministry of Health |
National public health institute
|
Regional health governance structure |
Public health officials |
National expert and/or advisory groups |
Healthcare professionals and/or management in hospitals |
Healthcare professionals and/or management in long term care |
Not applicable |
Other, namely |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE 5
You have stated that you believe less and/or other actors should have been involved in the development of the testing strategy throughout the COVID-19 pandemic.
Please fill in the matrix and select which actors you believe should have been involved in the development of the testing strategy for the different target groups throughout the COVID-19 pandemic.
Please select the appropriate options for each row. |
|
Laboratory in clinical institution |
Private laboratory |
Animal health laboratory |
Commercial manufacturers of testing kits and materials |
Ministry of Health |
Ministry other than the Ministry of Health |
National public health institute
|
Regional health governance structure |
Public health officials |
National expert and/or advisory groups |
Healthcare professionals and/or management in hospitals |
Healthcare professionals and/or management in long term care |
Not applicable |
Other, namely |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|